Cargando…

Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods

BACKGROUND: Numerous oral anticancer chemotherapies are available. Non-adherence or over-adherence to these chemotherapies can lead to lowered efficacy and increased risk of adverse events. The objective of this study was to identify patients’ adherence profiles using a qualitative–quantitative meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourmaud, Aurélie, Henin, Emilie, Tinquaut, Fabien, Regnier, Véronique, Hamant, Chloé, Colomban, Olivier, You, Benoit, Ranchon, Florence, Guitton, Jérôme, Girard, Pascal, Freyer, Gilles, Tod, Michel, Rioufol, Catherine, Trillet-Lenoir, Véronique, Chauvin, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490730/
https://www.ncbi.nlm.nih.gov/pubmed/26142140
http://dx.doi.org/10.1186/s13104-015-1231-8
_version_ 1782379561055420416
author Bourmaud, Aurélie
Henin, Emilie
Tinquaut, Fabien
Regnier, Véronique
Hamant, Chloé
Colomban, Olivier
You, Benoit
Ranchon, Florence
Guitton, Jérôme
Girard, Pascal
Freyer, Gilles
Tod, Michel
Rioufol, Catherine
Trillet-Lenoir, Véronique
Chauvin, Franck
author_facet Bourmaud, Aurélie
Henin, Emilie
Tinquaut, Fabien
Regnier, Véronique
Hamant, Chloé
Colomban, Olivier
You, Benoit
Ranchon, Florence
Guitton, Jérôme
Girard, Pascal
Freyer, Gilles
Tod, Michel
Rioufol, Catherine
Trillet-Lenoir, Véronique
Chauvin, Franck
author_sort Bourmaud, Aurélie
collection PubMed
description BACKGROUND: Numerous oral anticancer chemotherapies are available. Non-adherence or over-adherence to these chemotherapies can lead to lowered efficacy and increased risk of adverse events. The objective of this study was to identify patients’ adherence profiles using a qualitative–quantitative method. METHODS: A capecitabine treatment was initiated for 38 patients with advanced breast or colorectal cancer. At inclusion, information on patients’ beliefs was reported using a questionnaire. Later, Information on patients’ relation to treatment was obtained from a sub-group during an interview with a sociologist. Questionnaires were analyzed using Multiple Classification Analysis to cluster patients. Treatment adherence was evaluated by an electronic medication event monitoring systems (MEMS caps) and then correlated with patient clusters. Interviews were analyzed to complete and explain results. RESULTS: 38 patients were enrolled between 2008 and 2011 and completed the questionnaire. Twenty had adherence measured with MEMS caps all along treatment. Between 4 and 6 months after inclusion, 16 patients were interviewed. Patient profile B (retired, with a regular life, surrounded by a relative’s attention to drug adherence, with a low educational level) was statistically associated with adequate adherence (p = 0.049). A tendency for lower adherence was observed among more highly educated patients with an irregular, active life (NS). All patients taking capecitabine demonstrated a risk of over-adherence, potentiating side effects. CONCLUSIONS: These encouraging primary results suggest that further studies should be undertaken and that educational programs tailored to patient profiles should be evaluated to enhance adherence for those who need it and to empower all patients to manage treatment side effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-015-1231-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4490730
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44907302015-07-04 Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods Bourmaud, Aurélie Henin, Emilie Tinquaut, Fabien Regnier, Véronique Hamant, Chloé Colomban, Olivier You, Benoit Ranchon, Florence Guitton, Jérôme Girard, Pascal Freyer, Gilles Tod, Michel Rioufol, Catherine Trillet-Lenoir, Véronique Chauvin, Franck BMC Res Notes Research Article BACKGROUND: Numerous oral anticancer chemotherapies are available. Non-adherence or over-adherence to these chemotherapies can lead to lowered efficacy and increased risk of adverse events. The objective of this study was to identify patients’ adherence profiles using a qualitative–quantitative method. METHODS: A capecitabine treatment was initiated for 38 patients with advanced breast or colorectal cancer. At inclusion, information on patients’ beliefs was reported using a questionnaire. Later, Information on patients’ relation to treatment was obtained from a sub-group during an interview with a sociologist. Questionnaires were analyzed using Multiple Classification Analysis to cluster patients. Treatment adherence was evaluated by an electronic medication event monitoring systems (MEMS caps) and then correlated with patient clusters. Interviews were analyzed to complete and explain results. RESULTS: 38 patients were enrolled between 2008 and 2011 and completed the questionnaire. Twenty had adherence measured with MEMS caps all along treatment. Between 4 and 6 months after inclusion, 16 patients were interviewed. Patient profile B (retired, with a regular life, surrounded by a relative’s attention to drug adherence, with a low educational level) was statistically associated with adequate adherence (p = 0.049). A tendency for lower adherence was observed among more highly educated patients with an irregular, active life (NS). All patients taking capecitabine demonstrated a risk of over-adherence, potentiating side effects. CONCLUSIONS: These encouraging primary results suggest that further studies should be undertaken and that educational programs tailored to patient profiles should be evaluated to enhance adherence for those who need it and to empower all patients to manage treatment side effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13104-015-1231-8) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-04 /pmc/articles/PMC4490730/ /pubmed/26142140 http://dx.doi.org/10.1186/s13104-015-1231-8 Text en © Bourmaud et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bourmaud, Aurélie
Henin, Emilie
Tinquaut, Fabien
Regnier, Véronique
Hamant, Chloé
Colomban, Olivier
You, Benoit
Ranchon, Florence
Guitton, Jérôme
Girard, Pascal
Freyer, Gilles
Tod, Michel
Rioufol, Catherine
Trillet-Lenoir, Véronique
Chauvin, Franck
Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
title Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
title_full Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
title_fullStr Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
title_full_unstemmed Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
title_short Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
title_sort adherence to oral anticancer chemotherapy: what influences patients’ over or non-adherence? analysis of the octo study through quantitative–qualitative methods
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490730/
https://www.ncbi.nlm.nih.gov/pubmed/26142140
http://dx.doi.org/10.1186/s13104-015-1231-8
work_keys_str_mv AT bourmaudaurelie adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT heninemilie adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT tinquautfabien adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT regnierveronique adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT hamantchloe adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT colombanolivier adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT youbenoit adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT ranchonflorence adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT guittonjerome adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT girardpascal adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT freyergilles adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT todmichel adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT rioufolcatherine adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT trilletlenoirveronique adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods
AT chauvinfranck adherencetooralanticancerchemotherapywhatinfluencespatientsoverornonadherenceanalysisoftheoctostudythroughquantitativequalitativemethods